Chemoinformaics analysis of isoorientin 7-O-glucoside
| Molecular Weight | 610.521 | nRot | 6 |
| Heavy Atom Molecular Weight | 580.281 | nRig | 30 |
| Exact Molecular Weight | 610.153 | nRing | 5 |
| Solubility: LogS | -1.913 | nHRing | 3 |
| Solubility: LogP | -0.497 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 77.9258 |
| nHD | 11 | BPOL | 37.9082 |
| QED | 0.126 |
| Synth | 4.814 |
| Natural Product Likeliness | 1.774 |
| NR-PPAR-gamma | 0.192 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.994 |
| HIA | 0.983 |
| CACO-2 | -6.439 |
| MDCK | 0.0000224 |
| BBB | 0.128 |
| PPB | 0.775566 |
| VDSS | 0.61 |
| FU | 0.24154 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.012 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.093 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.002 |
| CL | 1.405 |
| T12 | 0.74 |
| hERG | 0.351 |
| Ames | 0.63 |
| ROA | 0.01 |
| SkinSen | 0.418 |
| Carcinogencity | 0.038 |
| EI | 0.032 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.832 |
| Antiviral | Yes |
| Prediction | 0.795319 |